Marion Déjosez

2.7k citations
24 papers · 914 indexed · h-index 14

Marion Déjosez

24 papers receiving 903 citations

Peers

Marion Déjosez
Comparison fields: 5 of 91
  • Aging 19
  • Molecular Biology 731
  • Cell Biology 102
  • Immunology 119
  • Developmental Neuroscience 22
Replace Sigrid Weiler with:
Sigrid Weiler Germany
Rubén Moreno Spain
Isabelle Guénal France
Emilie Besnard France
Karim Chébli France
Petr Kašpárek Czechia
Stephen J. Terry United Kingdom
R. Nicholas Laribee United States
Michael Zheng United States
Richard Silva Brazil
Marion Déjosez relative to Sigrid Weiler Germany Sigrid Weiler's profile →
Citations per field
00.5×1.5×2.1×
Sigrid Weiler · 1×
Citations per year

Countries citing papers authored by Marion Déjosez

Since Specialization
Citations

This map shows the geographic impact of Marion Déjosez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marion Déjosez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marion Déjosez more than expected).

Fields of papers citing papers by Marion Déjosez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marion Déjosez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marion Déjosez. The network helps show where Marion Déjosez may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Marion Déjosez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marion Déjosez Line = papers co-authored together Marion Déjosez links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20243
2 202323
3 20216
4 20196
5 20179
6 201714
7 20172
8 201625
9 201355
10 201098
11 2008229
12 2008159
13 200810
14 200617
15 20049
16 200328
17 200032
18 20009
19 200049
20
Resistance to CD95 (APO-1/Fas)-mediated apoptosis in human renal cell carcinomas: an important factor for evasion from negative growth control.
199930

About Marion Déjosez

Marion Déjosez is a scholar working on Molecular Biology, Biotechnology and Endocrinology, having authored 24 papers that have together received 914 indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (11 papers), CRISPR and Genetic Engineering (8 papers), Renal and related cancers (3 papers), Cancer Research and Treatments (2 papers), Mitochondrial Function and Pathology (2 papers), Cell death mechanisms and regulation (2 papers), Cancer-related Molecular Pathways (2 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Aging (19 citations), Molecular Biology (731 citations) and Cell Biology (102 citations). Marion Déjosez has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Thomas P. Zwaka, James A. Thomson, Jun Fujita, Richard A. Flavell, Ana M. Crane, Michael Kyba, Laura J. Zitur, Li‐Fang Chu, Joshua S. Krumenacker and Zhou Songyang. Their work appears in journals such as Science, Cell and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026